Related Experiment Video
Updated: Dec 18, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Stigma and Disclosure in Patients With Inflammatory Bowel Disease
Ling Guo1, Jacob Rohde2, Francis A Farraye1,3
1Section of Gastroenterology, Boston Medical Center, Boston, Massachusetts, USA.
Stigma negatively impacts patients with inflammatory bowel disease (IBD), worsening outcomes. Identifying and targeting specific IBD stigma forms can reduce psychological burden and improve physical health.
Area of Science:
- Gastroenterology and Psychology
Background:
- Chronic diseases, including Inflammatory Bowel Disease (IBD), are linked to stigma.
- Stigma correlates with adverse clinical outcomes, depression, anxiety, and reduced quality of life.
Purpose of the Study:
- To review the multifaceted nature of stigma in IBD patients.
- To explore the clinical significance of various stigma forms in IBD.
- To identify potential targets for interventions to mitigate stigma's impact.
Main Methods:
- Literature review examining public perception, knowledge, and stigmatization of IBD.
- Analysis of IBD stigma prevalence and its effects on patient outcomes.
- Review of IBD disclosure patterns and their association with stigma in different age groups.
Main Results:
- Stigma significantly impacts IBD patients' psychological and physical well-being.
- Understanding different forms of IBD stigma is crucial for effective intervention.
- Disclosure of IBD is associated with stigma, with varying effects in youth and adults.
Conclusions:
- Targeting specific forms of IBD stigma can alleviate psychological distress.
- Interventions aimed at reducing stigma may improve both mental and physical health in IBD patients.
- Further research into IBD stigma and disclosure is needed to develop effective therapeutic strategies.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

